The L1 $30m draw down agreement runs for another year until June 2024. Not touched so far, still the full amount available. While that doesn't rule out any other sort of CR it means additional funds aren't an issue at this stage.
Time will tell.
GLTA
Ann: Completion of Viral Vector Manufacturing for Phase 1 trial, page-15
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| CHM (ASX) Chart |
Day chart unavailable